Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All nigella sativa studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchNigella SativaNigella Sativa (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Computational Prediction of Nigella sativa Compounds as Potential Drug Agents for Targeting Spike Protein of SARS-CoV-2

Ali et al., Pakistan BioMedical Journal, doi:10.54393/pbmj.v6i3.853
Mar 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
12th treatment shown to reduce risk in January 2021
 
*, now with p = 0.00016 from 14 studies.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,500+ studies for 81 treatments. c19early.org
In Silico study identifying multiple compounds from nigella sativa as inhibitors of SARS-CoV-2. Methyl stearate showed the lowest binding energy and formed a stable complex with the spike protein.
20 preclinical studies support the efficacy of nigella sativa for COVID-19:
Ali et al., 31 Mar 2023, Pakistan, peer-reviewed, 8 authors. Contact: rashid.saif37@gmail.com.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
This PaperNigella SativaAll
Computational Prediction of Nigella sativa Compounds as Potential Drug Agents for Targeting Spike Protein of SARS-CoV-2
Laraib Ali, Rashid Saif, Muhammad Hassan Raza, Muhammad Osama Zafar, Saeeda Zia, Mehwish Shafiq, Tuba Ahmad, Iram Anjum
Pakistan BioMedical Journal, doi:10.54393/pbmj.v6i3.853
COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2, which is a member of the Coronaviridae family in the Nidovirales order [1]. The virus was rst identi ed in Wuhan, China in late 2019 and has since spread globally, leading to widespread illness and death [2]. Coronaviruses are responsible for a range of diseases, including respiratory, digestive, enteric, and neurological disorders [3]. The highly transmissible nature of the virus has resulted in its spread to 216 countries worldwide [4]. As of the latest reported gures, there have been 759,408,703 con rmed cases of 866,434 deaths
C o n  i c t s o f I n t e r e s t The authors declare no con ict of interest. S o u r c e o f F u n d i n g The authors received no nancial support for the research, authorship and/or publication of this article.
References
Coutard, Valle, De Lamballerie, Canard, Seidah et al., The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade, Antiviral
Cvetković, Nikolić, Nenadić, Öcal, Noji et al., Preparedness and preventive behaviors for a pandemic disaster caused by COVID-19 in Serbia, International Journal of Environmental Research and Public Health, doi:10.3390/erph17114124
Dias, De Azevedo, Molecular docking algorithms, Currents Drug Targets, doi:10.26434/chemrxiv.12055716
E F E R E N C E S Gorbalenya, Baker, Baric, De Groot, Drosten et al., The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, Nature Microbiology, doi:10.1038/s41564-020-0695-z
Kamble, Daulatabad, John, John, Synopsis of symptoms of COVID-19 during second wave of the pandemic in India, Hormone Molecular Biology and Clinical Investigation, doi:10.1515/hmbci-2021-0043
Ng, Li, Chua, Chaw, Zhao et al., Evaluation of the effectiveness of surveillance and containment measures for the rst 100 patients with COVID-19 in Singapore-January 2-February 29, Morbidity and Mortality Weekly Report, doi:10.15585/mmwr.mm6911e1
Yin, Li, Ye, Ruan, Liang et al., Molecular docking and dynamic simulation of Olea europaea and Curcuma Longa compounds as potential drug agents for targeting Main-Protease of SARS-nCoV2, doi:10.1016/j.csbj.2022.01
{ 'indexed': {'date-parts': [[2023, 4, 20]], 'date-time': '2023-04-20T05:56:44Z', 'timestamp': 1681970204575}, 'reference-count': 20, 'publisher': 'CrossLinks International Publishers', 'license': [ { 'start': { 'date-parts': [[2023, 3, 31]], 'date-time': '2023-03-31T00:00:00Z', 'timestamp': 1680220800000}, 'content-version': 'unspecified', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'abstract': '<jats:p>SARS-CoV-2 was first identified in Wuhan, China in December 2019 and has rapidly ' 'devastated worldwide. The lack of approved therapeutic drugs has intensified the global ' 'situation, so researchers are seeking potential treatments using regular drug agents and ' 'traditional herbs as well. Objectives: To identify new therapeutic agents from Nigella sativa ' 'against spike protein (PDB ID: 7BZ5) of SARS-CoV-2. Methods: The 46 compounds from N. sativa ' 'were docked with spike protein using Molecular Operating Environment (MOE) software and ' 'compared with commercially available anti-viral drugs e.g., Arbidol, Favipiravir, Remdesivir, ' 'Nelfinavir, Chloroquine, Hydroxychloroquine. The Molecular Dynamic Simulation (MDS) analysis ' 'was also applied to determine ligand-protein complex stability. Furthermore, the ' 'pharmacological properties of compounds were also analyzed using AdmetSAR and SwissADME. ' 'Results: Out of its total 46 ligands, 8 compounds i.e., Methyl stearate, Eicosadienoic acid, ' 'Oleic acid, Stearic acid, Linoleic acid, Myristoleic acid, Palmitic acid, and Farnesol were ' 'selected for further analysis based on their minimum binding energy ranges from -7.45 to ' '-7.07 kcal/mol. The docking scores of N. sativa phytocompounds were similar to drugs taken as ' 'control. Moreover, post simulation analysis of Methyl stearate complex predicted the most ' 'stable conformer. Conclusions: Further, in-vivo experiments are suggested to validate the ' 'medicinal use of Methyl stearate as potential inhibitors against spike protein of ' 'SARS-CoV-2.</jats:p>', 'DOI': '10.54393/pbmj.v6i3.853', 'type': 'journal-article', 'created': {'date-parts': [[2023, 4, 19]], 'date-time': '2023-04-19T11:50:20Z', 'timestamp': 1681905020000}, 'page': '18-23', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Computational Prediction of Nigella sativa Compounds as Potential Drug Agents for Targeting ' 'Spike Protein of SARS-CoV-2', 'prefix': '10.54393', 'author': [ {'given': 'Laraib', 'family': 'Ali', 'sequence': 'first', 'affiliation': []}, {'given': 'Rashid', 'family': 'Saif', 'sequence': 'additional', 'affiliation': []}, {'given': 'Muhammad', 'family': 'Hassan Raza', 'sequence': 'additional', 'affiliation': []}, {'given': 'Muhammad', 'family': 'Osama Zafar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Saeeda', 'family': 'Zia', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mehwish', 'family': 'Shafiq', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tuba', 'family': 'Ahmad', 'sequence': 'additional', 'affiliation': []}, {'given': 'Iram', 'family': 'Anjum', 'sequence': 'additional', 'affiliation': []}], 'member': '32784', 'published-online': {'date-parts': [[2023, 3, 31]]}, 'reference': [ { 'key': 'ref0', 'doi-asserted-by': 'publisher', 'unstructured': '1. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva ' 'AA, et al. The species Severe acute respiratory syndrome-related ' 'coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature ' 'Microbiology. 2020 Apr; 5(4): 536-44. doi: 10.1038/s41564-020-0695-z.', 'DOI': '10.1038/s41564-020-0695-z'}, { 'key': 'ref1', 'doi-asserted-by': 'publisher', 'unstructured': '2. Ng Y, Li Z, Chua YX, Chaw WL, Zhao Z, Er B, et al. Evaluation of the ' 'effectiveness of surveillance and containment measures for the first 100 ' 'patients with COVID-19 in Singapore-January 2-February 29, 2020. ' 'Morbidity and Mortality Weekly Report. 2020 Mar; 69(11): 307. doi: ' '10.15585/mmwr.mm6911e1.', 'DOI': '10.15585/mmwr.mm6911e1'}, { 'key': 'ref2', 'doi-asserted-by': 'publisher', 'unstructured': '3. Kamble P, Daulatabad V, John N, John J. Synopsis of symptoms of ' 'COVID-19 during second wave of the pandemic in India. Hormone Molecular ' 'Biology and Clinical Investigation. 2021 Dec; 43(1): 97-104. doi: ' '10.1515/hmbci-2021-0043.', 'DOI': '10.1515/hmbci-2021-0043'}, { 'key': 'ref3', 'doi-asserted-by': 'publisher', 'unstructured': '4. Cvetković VM, Nikolić N, Radovanović Nenadić U, Öcal A, K. Noji E, ' 'Zečević M. Preparedness and preventive behaviors for a pandemic disaster ' 'caused by COVID-19 in Serbia. International Journal of Environmental ' 'Research and Public Health. 2020 Jun; 17(11): 4124. doi: ' '10.3390/ijerph17114124.', 'DOI': '10.3390/ijerph17114124'}, { 'key': 'ref4', 'doi-asserted-by': 'publisher', 'unstructured': '5. Coutard B, Valle C, De Lamballerie X, Canard B, Seidah NG, Decroly E. ' 'The spike glycoprotein of the new coronavirus 2019-nCoV contains a ' 'furin-like cleavage site absent in CoV of the same clade. Antiviral ' 'Research. 2020 Apr; 176: 104742. doi: 10.1016/j.jare.2020.03.005.', 'DOI': '10.1016/j.jare.2020.03.005'}, { 'key': 'ref5', 'doi-asserted-by': 'publisher', 'unstructured': '6. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 ' 'infection: Emergence, transmission, and characteristics of human ' 'coronaviruses. Journal of Advanced Research. 2020 Jul; 24: 91-8. doi: ' '10.1016/j.jare.2020.03.005.', 'DOI': '10.1016/j.jare.2020.03.005'}, { 'key': 'ref6', 'doi-asserted-by': 'publisher', 'unstructured': '7. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and ' 'diagnosis of COVID-19. Journal of Pharmaceutical Analysis. 2020 Apr; ' '10(2): 102-8. doi: 10.1016/j.jpha.2020.03.001.', 'DOI': '10.1016/j.jpha.2020.03.001'}, { 'key': 'ref7', 'doi-asserted-by': 'publisher', 'unstructured': '8. Gyebi GA, Adegunloye AP, Ibrahim IM, Ogunyemi OM, Afolabi SO, Ogunro ' 'OB. Prevention of SARS-CoV-2 cell entry: insight from in silico ' 'interaction of drug-like alkaloids with spike glycoprotein, human ACE2, ' 'and TMPRSS2. Journal of Biomolecular Structure and Dynamics. 2022 Mar; ' '40(5): 2121-45. doi: 10.1080/07391102.2020.1835726.', 'DOI': '10.1080/07391102.2020.1835726'}, { 'key': 'ref8', 'doi-asserted-by': 'publisher', 'unstructured': '9. Shajahan A, Supekar NT, Gleinich AS, Azadi P. Deducing the N-and ' 'O-glycosylation profile of the spike protein of novel coronavirus ' 'SARS-CoV-2. Glycobiology. 2020 Dec; 30(12): 981-8. doi: ' '10.1093/glycob/cwaa042.', 'DOI': '10.1093/glycob/cwaa042'}, { 'key': 'ref9', 'doi-asserted-by': 'publisher', 'unstructured': '10. Li X, Luk HKH, Lau SKP, Woo PCY. Human Coronaviruses: General ' 'Features. Reference Module in Biomedical Sciences. 2019: ' 'B978-0-12-801238-3.95704-0. doi: 10.1016/B978-0-12-801238-3.95704-0.', 'DOI': '10.1016/B978-0-12-801238-3.95704-0'}, { 'key': 'ref10', 'doi-asserted-by': 'publisher', 'unstructured': '11. Yang H and Rao Z. Structural biology of SARS-CoV-2 and implications ' 'for therapeutic development. Nature Reviews Microbiology. 2021 Nov; ' '19(11): 685-700. doi: 10.1038/s41579-021-00630-8.', 'DOI': '10.1038/s41579-021-00630-8'}, { 'key': 'ref11', 'doi-asserted-by': 'publisher', 'unstructured': '12. Iqbal Yatoo M, Hamid Z, Parray OR, Wani AH, Ul Haq A, Saxena A, et ' 'al. COVID-19-Recent advancements in identifying novel vaccine candidates ' 'and current status of upcoming SARS-CoV-2 vaccines. Human Vaccines & ' 'Immunotherapeutics. 2020 Dec; 16(12): 2891-904. doi: ' '10.1080/21645515.2020.1788310.', 'DOI': '10.1080/21645515.2020.1788310'}, { 'key': 'ref12', 'doi-asserted-by': 'publisher', 'unstructured': '13. Sytar O, Brestic M, Hajihashemi S, Skalicky M, Kubeš J, ' 'Lamilla-Tamayo L, et al. COVID-19 prophylaxis efforts based on natural ' 'antiviral plant extracts and their compounds. Molecules. 2021 Jan; ' '26(3): 727. doi: 10.3390/molecules26030727.', 'DOI': '10.3390/molecules26030727'}, { 'key': 'ref13', 'doi-asserted-by': 'publisher', 'unstructured': '14. Imran M, Khan SA, Alshammari MK, Alkhaldi SM, Alshammari FN, Kamal ' 'M, et al. Nigella sativa L. and COVID-19: A glance at the anti-COVID-19 ' 'chemical constituents, clinical trials, inventions, and patent ' 'literature. Molecules. 2022 Apr; 27(9): 2750. doi: ' '10.3390/molecules27092750.', 'DOI': '10.3390/molecules27092750'}, { 'key': 'ref14', 'doi-asserted-by': 'publisher', 'unstructured': '15. Bouchentouf S and Missoum N. Identification of Compounds from ' 'Nigella Sativa as New Potential Inhibitors of 2019 Novel Coronasvirus ' '(Covid-19): Molecular Docking Study. 2020 Apr: 1-12. doi: ' '10.26434/chemrxiv.12055716.v1.', 'DOI': '10.26434/chemrxiv.12055716.v1'}, { 'key': 'ref15', 'doi-asserted-by': 'publisher', 'unstructured': '16. Dias R and de Azevedo WF Jr. Molecular docking algorithms. Currents ' 'Drug Targets. 2008 Dec; 9(12): 1040-7. doi: 10.2174/138945008786949432.', 'DOI': '10.2174/138945008786949432'}, { 'key': 'ref16', 'doi-asserted-by': 'publisher', 'unstructured': '17. Yin J, Li C, Ye C, Ruan Z, Liang Y, Li Y, et al. Advances in the ' 'development of therapeutic strategies against COVID-19 and perspectives ' 'in the drug design for emerging SARS-CoV-2 variants. Computational and ' 'Structural Biotechnology Journal. 2022 Jan; 20: 824-837. doi: ' '10.1016/j.csbj.2022.01.026.', 'DOI': '10.1016/j.csbj.2022.01.026'}, { 'key': 'ref17', 'doi-asserted-by': 'publisher', 'unstructured': '18. Saif R, Raza MH, Rehman T, Zafar MO, Zia S, Qureshi AR. Molecular ' 'docking and dynamic simulation of Olea europaea and Curcuma Longa ' 'compounds as potential drug agents for targeting Main-Protease of ' 'SARS-nCoV2. Biological and Medicinal Chemistry. 2021 Mar: 1-22. doi: ' '10.26434/chemrxiv.13246739.v2.', 'DOI': '10.26434/chemrxiv.13246739.v2'}, { 'key': 'ref18', 'doi-asserted-by': 'publisher', 'unstructured': '19. Saif R, Zafar MO, Raza MH, Zia S, Qureshi AR. Computational ' 'prediction of Carica papaya phytocompounds as potential drug agent ' 'against RdRp and spike protein of SARS-nCoV2 by molecular docking and ' 'dynamics simulation approaches. Research Square. 2022 Aug. doi: ' '10.21203/rs.3.rs-105301/v2.', 'DOI': '10.21203/rs.3.rs-105301/v2'}, { 'key': 'ref19', 'doi-asserted-by': 'publisher', 'unstructured': '20. Naqvi AA, Mohammad T, Hasan GM, Hassan M. Advancements in docking ' 'and molecular dynamics simulations towards ligand-receptor interactions ' 'and structure-function relationships. Current Topics in Medicinal ' 'Chemistry. 2018 Aug; 18(20): 1755-68. doi: ' '10.2174/1568026618666181025114157.', 'DOI': '10.2174/1568026618666181025114157'}], 'container-title': 'Pakistan BioMedical Journal', 'original-title': [], 'link': [ { 'URL': 'https://pakistanbmj.com/journal/index.php/pbmj/article/download/853/674', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://pakistanbmj.com/journal/index.php/pbmj/article/download/853/675', 'content-type': 'application/vnd.openxmlformats-officedocument.wordprocessingml.document', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://pakistanbmj.com/journal/index.php/pbmj/article/download/853/674', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 4, 19]], 'date-time': '2023-04-19T11:50:31Z', 'timestamp': 1681905031000}, 'score': 1, 'resource': {'primary': {'URL': 'https://pakistanbmj.com/journal/index.php/pbmj/article/view/853'}}, 'subtitle': ['Computational Prediction of N. sativa Compounds as Potential Drug Agents'], 'short-title': [], 'issued': {'date-parts': [[2023, 3, 31]]}, 'references-count': 20, 'URL': 'http://dx.doi.org/10.54393/pbmj.v6i3.853', 'relation': {}, 'ISSN': ['2709-2798', '2709-278X'], 'subject': ['General Engineering'], 'container-title-short': 'PBMJ', 'published': {'date-parts': [[2023, 3, 31]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit